Response Genetics' Q1 Revenues Fall 32 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics today reported a 32 percent drop year over year in its first-quarter revenues.

For the period ended March 31, the Los Angeles-based molecular diagnostics firm recorded $4 million in revenues, down from $5.9 million a year ago. The company attributed the drop to a decrease in its pharmaceutical-related business, while revenues from its Response DX genetic tests dropped to $3 million from $3.1 million.

Its net loss for the period spiked to $3.1 million, or $.14 per share, from $256,891, or $.01 per share, a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.